Evidence map›Paper›PMID 35328628›Full record

ArticleInternational journal of molecular sciences2022

The mRubyFT Protein, Genetically Encoded Blue-to-Red Fluorescent Timer.

Oksana M Subach, Aleksandr Tashkeev, Anna V Vlaskina, Dmitry E Petrenko, Filipp A Gaivoronskii, Alena Y Nikolaeva, Olga I Ivashkina, Konstantin V Anokhin, Vladimir O Popov, Konstantin M Boyko and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Oksana M SubachComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Aleksandr TashkeevUnit of Animal Genomics, GIGA Research Center, University of Liège, 4000 Liege, Belgium.
Anna V VlaskinaComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Dmitry E PetrenkoComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Filipp A GaivoronskiiBach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.
Alena Y NikolaevaComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Olga I IvashkinaComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Konstantin V AnokhinLaboratory for Neurobiology of Memory, P.K. Anokhin Research Institute of Normal Physiology, 125315 Moscow, Russia.
Vladimir O PopovComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Konstantin M BoykoBach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.ORCID 0000-0001-8229-189X
Fedor V SubachComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.ORCID 0000-0003-2720-7821
Kurchatov Institute · RULomonosov Moscow State University · RUMoscow Institute of Physics and Technology · RUUniversity of Liège · BE

Funding

Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS) under ASP/ AR 414 grant to A.T.internal grant of the National Research Center Kurchatov Institute №2752 of 28.10.2021NRC Kurchatov institute tematic plan1.1Russian Foundation for Basic Research 19-04-00395Russian Foundation for Basic Research 20-015-00427Russian Science Foundation 21-74-20135the Ministry of Science and Higher Education of the Russian Federation 075-15-2020-801
6 · The paper itself

Abstract

Genetically encoded monomeric blue-to-red fluorescent timers (mFTs) change their fluorescent color over time. mCherry-derived mFTs were used for the tracking of the protein age, visualization of the protein trafficking, and labeling of engram cells. However, the brightness of the blue and red forms of mFTs are 2-3- and 5-7-fold dimmer compared to the brightness of the enhanced green fluorescent protein (EGFP). To address this limitation, we developed a blue-to-red fluorescent timer, named mRubyFT, derived from the bright mRuby2 red fluorescent protein. The blue form of mRubyFT reached its maximum at 5.7 h and completely transformed into the red form that had a maturation half-time of 15 h. Blue and red forms of purified mRubyFT were 4.1-fold brighter and 1.3-fold dimmer than the respective forms of the mCherry-derived Fast-FT timer in vitro. When expressed in mammalian cells, both forms of mRubyFT were 1.3-fold brighter than the respective forms of Fast-FT. The violet light-induced blue-to-red photoconversion was 4.2-fold less efficient in the case of mRubyFT timer compared to the same photoconversion of the Fast-FT timer. The timer behavior of mRubyFT was confirmed in mammalian cells. The monomeric properties of mRubyFT allowed the labeling and confocal imaging of cytoskeleton proteins in live mammalian cells. The X-ray structure of the red form of mRubyFT at 1.5 Å resolution was obtained and analyzed. The role of the residues from the chromophore surrounding was studied using site-directed mutagenesis.

Indexed as

LightMammalsAnimalsGreen Fluorescent ProteinsLuminescent ProteinsMutagenesis, Site-DirectedGreen Fluorescent ProteinsLuminescent Proteinsfluorescence imagingfluorescent proteingenetically encoded blue-to-red fluorescent timersmRubyFTprotein engineeringRubyFT#11-9X-ray structure

Identifiers

PMID35328628
PMCPMC8952768
OpenAlexW4220657159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.